# NexPoint Residential Trust, Inc.: overview

NXRT · NYSE · CIK 1620393 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxrt.md) · [Financials](/companies/nxrt/financials.md) · [Filings](/companies/nxrt/filings.md) · [Insiders](/companies/nxrt/insiders.md)

Latest reported revenue: [$64.6m](/filings/0001193125-26-333942.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-333942).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [64.1](/filings/0001193125-25-254873.md) | [63.8 d](/filings/0001193125-26-077343.md) | [63.2](/filings/0001193125-26-192096.md) | [63.1](/filings/0001193125-26-333942.md) | [62.8](/filings/0001193125-25-254873.md) | [62.1 d](/filings/0001193125-26-077343.md) | [63.5](/filings/0001193125-26-192096.md) | [64.6](/filings/0001193125-26-333942.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.7%](/filings/0001193125-25-254873.md) | [18.0% d](/filings/0001193125-26-077343.md) | [11.7%](/filings/0001193125-26-192096.md) | [12.5%](/filings/0001193125-26-333942.md) | [11.8%](/filings/0001193125-25-254873.md) | [8.4% d](/filings/0001193125-26-077343.md) | [13.4%](/filings/0001193125-26-192096.md) | [10.9%](/filings/0001193125-26-333942.md) |
| Net margin | % | [(13.8%)](/filings/0001193125-25-254873.md) | [(42.2%) d](/filings/0001193125-26-077343.md) | [(10.9%)](/filings/0001193125-26-192096.md) | [(11.1%)](/filings/0001193125-26-333942.md) | [(12.4%)](/filings/0001193125-25-254873.md) | [(16.6%) d](/filings/0001193125-26-077343.md) | [(10.6%)](/filings/0001193125-26-192096.md) | [(13.3%)](/filings/0001193125-26-333942.md) |
| Diluted EPS | $ per share | [(0.35)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.28)](/filings/0001193125-26-333942.md) | [(0.31)](/filings/0001193125-25-254873.md) | not reported | [(0.27)](/filings/0001193125-26-192096.md) | [(0.34)](/filings/0001193125-26-333942.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [219](/filings/0000950170-24-021143.md) | [264](/filings/0000950170-25-027741.md) | [278](/filings/0001193125-26-077343.md) | [260](/filings/0001193125-26-077343.md) | [251](/filings/0001193125-26-077343.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [29.4%](/filings/0000950170-24-021143.md) | [17.5%](/filings/0000950170-25-027741.md) | [40.8%](/filings/0001193125-26-077343.md) | [32.2%](/filings/0001193125-26-077343.md) | [11.1%](/filings/0001193125-26-077343.md) |
| Net margin | % | [10.5%](/filings/0000950170-24-021143.md) | [(3.5%)](/filings/0000950170-25-027741.md) | [15.9%](/filings/0001193125-26-077343.md) | [0.4%](/filings/0001193125-26-077343.md) | [(12.7%)](/filings/0001193125-26-077343.md) |
| Diluted EPS | $ per share | [0.89](/filings/0000950170-24-021143.md) | [(0.36)](/filings/0000950170-25-027741.md) | [1.69](/filings/0001193125-26-077343.md) | [0.04](/filings/0001193125-26-077343.md) | [(1.26)](/filings/0001193125-26-077343.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nxrt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $118.7m | 4,253,149 |  | Added +41,021 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $38.1m | 1,363,544 |  | Reduced −7,192 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $35.6m | 1,274,198 |  | Added +79,147 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $30.6m | 1,095,650 |  | Reduced −201,583 |
| [Starwood Capital Group Management, L.L.C.](/funds/1388788.md) | 2026-06-30 | $27.6m | 989,419 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $26.8m | 961,351 |  | Added +9,454 |
| [NEXPOINT ASSET MANAGEMENT, L.P.](/funds/1469877.md) | 2026-06-30 | $26.1m | 934,752 |  | Unchanged |
| [Copeland Capital Management, LLC](/funds/1541743.md) | 2026-06-30 | $25.1m | 899,504 |  | Added +171,333 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $18.1m | 647,524 |  | Added +36,444 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $13.5m | 482,632 |  | Added +139,429 |

## Recent filings

[All 687 filings](/companies/nxrt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 16:17 ET | [SCHEDULE 13D/A](/filings/0001437749-26-031229.md) | Ownership report, active investor, amended | 0001437749-26-031229 |
| 2026-08-05 | 08:21 ET | [10-Q](/filings/0001193125-26-333942.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333942 |
| 2026-08-04 | 08:23 ET | [8-K](/filings/0001193125-26-331611.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331611 |
| 2026-06-09 | 16:21 ET | [8-K](/filings/0001437749-26-020003.md) | 1.01 Entry into a material agreement | 0001437749-26-020003 |
| 2026-06-02 | 16:20 ET | [8-K](/filings/0001437749-26-019168.md) | 5.07 Shareholder vote results | 0001437749-26-019168 |
| 2026-04-29 | 16:53 ET | [10-Q](/filings/0001193125-26-192096.md) | Quarterly report, period 2026-03-31 | 0001193125-26-192096 |
| 2026-04-28 | 08:16 ET | [8-K](/filings/0001193125-26-183645.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-183645 |
| 2026-04-10 | 16:15 ET | [DEF 14A](/filings/0001437749-26-012026.md) | Proxy statement, period 2026-06-02 | 0001437749-26-012026 |
| 2026-02-26 | 17:12 ET | [10-K](/filings/0001193125-26-077343.md) | Annual report, period 2025-12-31 | 0001193125-26-077343 |
| 2026-02-24 | 08:16 ET | [8-K](/filings/0001193125-26-065382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-065382 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-077343.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/fbe3afa3-036f-4cb1-82bf-cdf7eff83b36)

## About the filer

- CIK: 1620393
- Tickers: NXRT
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:57 ET. No prices; not investment advice.